Exact Mass: 368.0651688
Exact Mass Matches: 368.0651688
Found 50 metabolites which its exact mass value is equals to given mass value 368.0651688,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
3'-O-Methyl-(-)-epicatechin-7-O-sulphate
3-O-Methyl-(-)-epicatechin-7-O-sulphate is an urinary and gut-derived metabolite of epicatechin.
O1-{[5-(3-Thienyl)-1,2,4-oxadiazol-3-yl]methyl}-4-(trifluoromethyl)benzene-1-carbohydroximamide
(6S)-7-chloro-6-hydroxy-2,4,6-trimethoxy-6-methyl-3H-spiro[benzofuran-2,1-cyclohex[2]ene]-3,4-dione
5,7-dihydroxychromone-7-O-beta-D-glucuronide methyl ester|7-(methyl glucuronide)-5-hydroxychromone
2-O-caffeoylisocitric acid 6-methyl ester|E-2-(3-(3,4-dihydroxyphenyl)prop-2-enoyloxy)-3-(methoxycarbonyl)pentanedioic acid
Spiro[benzofuran-2(3H),1-[2]cyclohexene]-3,4-dione, 7-chloro-5-hydroxy-2,4,6-trimethoxy-6-methyl-, [1S-(1.alpha.,5.beta.,6.beta.)]-
3-hydroxy-2-[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy-3-methoxycarbonylpentanedioic acid
2-Deoxy-4-O-[(2E)-3-(4-hydroxyphenyl)-2-propenoyl]-3-C-(methoxycarbonyl)pentaric acid
tert-Butyl 4-(4-bromo-2-formylphenyl)piperazine-1-carboxylate
4-(3-BROMO-BENZOYL)-PIPERAZINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER
Adenosine 5′-monophosphoramidate sodium
C10H14N6NaO6P (368.06101140000004)
Adenosine 5′-monophosphoramidate sodium is an adenosine derivative and can be used as an intermediate for nucleotide synthesis. Adenosine 5′-monophosphoramidate has a significant effect on the accumulation of cyclic AMP[1]. Adenosine 5′-monophosphoramidate sodium is an adenosine derivative and can be used as an intermediate for nucleotide synthesis. Adenosine 5′-monophosphoramidate has a significant effect on the accumulation of cyclic AMP[1].
4-(4-BROMO-BENZOYL)-PIPERAZINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER
n,n-difluoro-2,2-bipyridinium bis(tetrafluoroborate)
C10H8B2F10N2 (368.07138679999997)
2,3-Diphenyl-5-(4-chlorophenyl)tetrazolium Chloride
4-Fluorobenzoic acid 4-[(5-phenyl-1,3,4-oxadiazol-2-yl)thio]but-2-ynyl ester
2-[3-Chloro-5-(trifluoromethyl)-2-pyridinyl]-5-methyl-4-(4-methylphenyl)-1,2,4-triazol-3-one
2-(beta-D-glucopyranosyluronate)-D-glucuronate(2-)
N-[(E)-1-(2,4-dichlorophenyl)methylidene]-N-phenyl-2-pyridinecarbohydrazonamide
5-ethyl-4-oxo-N-(thiophen-2-ylmethyl)-2-thieno[3,2-c]quinolinecarboxamide
C19H16N2O2S2 (368.06531559999996)
4-O-alpha-D-galactopyranuronosyl-D-galactopyranuronate
1-Tert-butyl-5-[(2,4-dichloro-5-fluorophenyl)methyl]-4-pyrazolo[3,4-d]pyrimidinone
C16H15Cl2FN4O (368.06068919999996)
3,4,5-Trihydroxy-6-[3-(hydroxymethyl)-1-oxoisochromen-7-yl]oxyoxane-2-carboxylic acid
[3,5,6-trihydroxy-2-(3-methoxyphenyl)-3,4-dihydro-2H-chromen-7-yl] hydrogen sulfite
3-hydroxy-2-[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy-3-methoxycarbonylpentanedioic acid
alpha-D-GalpA-(1->4)-alpha-D-GalpA(2-)
An alpha-D-GalpA-(1->4)-D-GalpA(2-) in which both galacturonate units have alpha-D configuration.
WZB117
WZB117 is a glucose transporter 1 (Glut1) inhibitor, which downregulates glycolysis, induces cell-cycle arrest, and inhibits cancer cell growth in vitro and in vivo.
[(3as,4r,9r,10as)-5,10,10-trihydroxy-4-(hydroxymethyl)-2,6-diimino-hexahydropyrrolo[1,2-c]purin-9-yl]oxidanesulfonic acid
C9H16N6O8S (368.07502960000005)
methyl (2s,3s,4s,5r,6s)-3,4,5-trihydroxy-6-[(5-hydroxy-4-oxochromen-7-yl)oxy]oxane-2-carboxylate
7-chloro-6'-hydroxy-2',4,6-trimethoxy-6'-methylspiro[1-benzofuran-2,1'-cyclohexan]-2'-ene-3,4'-dione
[(3as,4r,10as)-5,10,10-trihydroxy-4-(hydroxymethyl)-2,6-diimino-hexahydropyrrolo[1,2-c]purin-9-yl]oxidanesulfonic acid
C9H16N6O8S (368.07502960000005)
methyl 3,4,5-trihydroxy-6-[(5-hydroxy-4-oxochromen-7-yl)oxy]oxane-2-carboxylate
[(3as,4r,9s,10as)-5,10,10-trihydroxy-4-(hydroxymethyl)-2,6-diimino-hexahydropyrrolo[1,2-c]purin-9-yl]oxidanesulfonic acid
C9H16N6O8S (368.07502960000005)